Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Tadmor

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|January 18, 2014
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?Meirav Kedmi, Irit Avivi, Elena Ribakovsky, et al.
Plos One|March 10, 2020
Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathwayRegina Michelis, Tamar Tadmor, Ariel Aviv, et al.
Frontiers in Immunology|September 19, 2022
Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemiaRegina Michelis, Lama Milhem, Evleen Galouk, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2025
Implementation of an integrative safety consultation service for the use of dietary and herbal supplements among patients with hematological diseasesIlana Levy Yurkovski, Sohair Bishara-Swaid, Ohad Cohen-Naznin, et al.
Haematologica|May 7, 2026
Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter's transformation: results from the phase II GIVeRS trialTamar Tadmor, Ohad Benjamini, Neta Goldschmidt, et al.
European Journal of Haematology|February 20, 2014
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study GroupLev Shvidel, Tamar Tadmor, Andrei Braester, et al.
Annals of Hematology|January 1, 2013
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 casesLev Shvidel, Tamar Tadmor, Andrei Braester, et al.
European Journal of Haematology|October 5, 2012
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study GroupOsnat Bairey, Neta Goldschmidt, Rosa Ruchlemer, et al.
Journal of Clinical Medicine|June 27, 2024
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical PracticeMartin H Ellis, Tamar Tadmor, Naama Yekutiel, et al.
Plos One|January 3, 2019
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activityRegina Michelis, Tamar Tadmor, Masad Barhoum, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|January 18, 2014
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?Meirav Kedmi, Irit Avivi, Elena Ribakovsky, et al.
Plos One|March 10, 2020
Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathwayRegina Michelis, Tamar Tadmor, Ariel Aviv, et al.
Frontiers in Immunology|September 19, 2022
Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemiaRegina Michelis, Lama Milhem, Evleen Galouk, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2025
Implementation of an integrative safety consultation service for the use of dietary and herbal supplements among patients with hematological diseasesIlana Levy Yurkovski, Sohair Bishara-Swaid, Ohad Cohen-Naznin, et al.
Haematologica|May 7, 2026
Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter's transformation: results from the phase II GIVeRS trialTamar Tadmor, Ohad Benjamini, Neta Goldschmidt, et al.
European Journal of Haematology|February 20, 2014
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study GroupLev Shvidel, Tamar Tadmor, Andrei Braester, et al.
Annals of Hematology|January 1, 2013
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 casesLev Shvidel, Tamar Tadmor, Andrei Braester, et al.
European Journal of Haematology|October 5, 2012
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study GroupOsnat Bairey, Neta Goldschmidt, Rosa Ruchlemer, et al.
Journal of Clinical Medicine|June 27, 2024
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical PracticeMartin H Ellis, Tamar Tadmor, Naama Yekutiel, et al.
Plos One|January 3, 2019
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activityRegina Michelis, Tamar Tadmor, Masad Barhoum, et al.
Pageof 15